Takara Bio Inc. (4974.T)
JPY 1002.0
(-0.2%)
JPY 1002.0
(-0.2%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 11.85 Billion JPY | 6.88% |
| 2022 | 11.08 Billion JPY | -53.93% |
| 2021 | 24.06 Billion JPY | 162.06% |
| 2020 | 9.18 Billion JPY | 20.94% |
| 2019 | 7.59 Billion JPY | 12.74% |
| 2018 | 6.73 Billion JPY | 12.06% |
| 2017 | 6.01 Billion JPY | 10.05% |
| 2016 | 5.46 Billion JPY | 7.1% |
| 2015 | 5.09 Billion JPY | 9.96% |
| 2014 | 4.63 Billion JPY | 4.91% |
| 2013 | 4.42 Billion JPY | 27.52% |
| 2012 | 3.46 Billion JPY | 12.06% |
| 2011 | 3.09 Billion JPY | 7.36% |
| 2010 | 2.88 Billion JPY | -6.31% |
| 2009 | 3.07 Billion JPY | -6.42% |
| 2008 | 3.28 Billion JPY | 3.46% |
| 2007 | 3.17 Billion JPY | -9.08% |
| 2006 | 3.49 Billion JPY | -11.41% |
| 2005 | 3.94 Billion JPY | 63.75% |
| 2004 | 2.4 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 12.92 Billion JPY | 9.03% |
| 2023 Q1 | 11.33 Billion JPY | 2.2% |
| 2023 FY | 11.85 Billion JPY | 6.88% |
| 2023 Q3 | 13.61 Billion JPY | 14.88% |
| 2023 Q4 | 11.85 Billion JPY | -12.98% |
| 2023 Q2 | 11.85 Billion JPY | 4.62% |
| 2022 Q4 | 11.08 Billion JPY | -27.41% |
| 2022 Q2 | 24.11 Billion JPY | -3.39% |
| 2022 Q1 | 24.96 Billion JPY | 3.73% |
| 2022 FY | 11.08 Billion JPY | -53.93% |
| 2022 Q3 | 15.27 Billion JPY | -36.67% |
| 2021 Q1 | 9.9 Billion JPY | 7.83% |
| 2021 Q2 | 10.68 Billion JPY | 7.95% |
| 2021 Q3 | 10.97 Billion JPY | 2.64% |
| 2021 FY | 24.06 Billion JPY | 162.06% |
| 2021 Q4 | 24.06 Billion JPY | 119.35% |
| 2020 Q3 | 9.39 Billion JPY | 6.25% |
| 2020 Q2 | 8.84 Billion JPY | 6.76% |
| 2020 FY | 9.18 Billion JPY | 20.94% |
| 2020 Q1 | 8.28 Billion JPY | 9.11% |
| 2020 Q4 | 9.18 Billion JPY | -2.29% |
| 2019 Q4 | 7.59 Billion JPY | -1.49% |
| 2019 Q3 | 7.7 Billion JPY | 8.08% |
| 2019 FY | 7.59 Billion JPY | 12.74% |
| 2019 Q2 | 7.13 Billion JPY | -0.82% |
| 2019 Q1 | 7.19 Billion JPY | 6.77% |
| 2018 Q4 | 6.73 Billion JPY | -16.56% |
| 2018 Q3 | 8.07 Billion JPY | 20.84% |
| 2018 FY | 6.73 Billion JPY | 12.06% |
| 2018 Q2 | 6.68 Billion JPY | 0.41% |
| 2018 Q1 | 6.65 Billion JPY | 10.7% |
| 2017 Q3 | 7.23 Billion JPY | 13.46% |
| 2017 Q2 | 6.38 Billion JPY | 1.08% |
| 2017 Q1 | 6.31 Billion JPY | 15.58% |
| 2017 FY | 6.01 Billion JPY | 10.05% |
| 2017 Q4 | 6.01 Billion JPY | -16.98% |
| 2016 Q2 | 5.38 Billion JPY | 2.51% |
| 2016 Q3 | 5.81 Billion JPY | 7.93% |
| 2016 FY | 5.46 Billion JPY | 7.1% |
| 2016 Q1 | 5.25 Billion JPY | 3.08% |
| 2016 Q4 | 5.46 Billion JPY | -6.09% |
| 2015 Q3 | 5.44 Billion JPY | 1.7% |
| 2015 Q1 | 5.07 Billion JPY | 9.51% |
| 2015 FY | 5.09 Billion JPY | 9.96% |
| 2015 Q2 | 5.35 Billion JPY | 5.49% |
| 2015 Q4 | 5.09 Billion JPY | -6.41% |
| 2014 Q3 | 5.16 Billion JPY | 6.6% |
| 2014 Q2 | 4.84 Billion JPY | 3.08% |
| 2014 Q1 | 4.7 Billion JPY | 6.43% |
| 2014 Q4 | 4.63 Billion JPY | -10.29% |
| 2014 FY | 4.63 Billion JPY | 4.91% |
| 2013 FY | 4.42 Billion JPY | 27.52% |
| 2013 Q2 | 4.32 Billion JPY | 5.61% |
| 2013 Q1 | 4.09 Billion JPY | 18.23% |
| 2013 Q4 | 4.42 Billion JPY | -3.47% |
| 2013 Q3 | 4.57 Billion JPY | 5.8% |
| 2012 Q3 | 3.61 Billion JPY | 12.59% |
| 2012 Q1 | 3.24 Billion JPY | 4.82% |
| 2012 Q2 | 3.2 Billion JPY | -1.05% |
| 2012 Q4 | 3.46 Billion JPY | -4.04% |
| 2012 FY | 3.46 Billion JPY | 12.06% |
| 2011 Q3 | 3.16 Billion JPY | 6.49% |
| 2011 Q4 | 3.09 Billion JPY | -2.34% |
| 2011 Q1 | 2.95 Billion JPY | 2.46% |
| 2011 FY | 3.09 Billion JPY | 7.36% |
| 2011 Q2 | 2.97 Billion JPY | 0.75% |
| 2010 Q2 | 2.94 Billion JPY | 3.92% |
| 2010 Q4 | 2.88 Billion JPY | -3.22% |
| 2010 Q3 | 2.97 Billion JPY | 1.19% |
| 2010 Q1 | 2.83 Billion JPY | -7.93% |
| 2010 FY | 2.88 Billion JPY | -6.31% |
| 2009 Q3 | 3.28 Billion JPY | 4.02% |
| 2009 FY | 3.07 Billion JPY | -6.42% |
| 2009 Q4 | 3.07 Billion JPY | -6.36% |
| 2009 Q2 | 3.15 Billion JPY | 0.0% |
| 2008 Q4 | 3.28 Billion JPY | 0.0% |
| 2008 FY | 3.28 Billion JPY | 3.46% |
| 2007 FY | 3.17 Billion JPY | -9.08% |
| 2006 FY | 3.49 Billion JPY | -11.41% |
| 2005 FY | 3.94 Billion JPY | 63.75% |
| 2004 FY | 2.4 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | -1634.967% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -65994.038% |
| GNI Group Ltd. | 2.33 Billion JPY | -408.448% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | -431.939% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -17460.499% |
| Soiken Holdings Inc. | 1.12 Billion JPY | -957.215% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | -11345.515% |
| AnGes, Inc. | 1.61 Billion JPY | -633.378% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -15913.73% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | -308.198% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | -3581.119% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -6440117.391% |
| Carna Biosciences, Inc. | 140.14 Million JPY | -8355.83% |
| CanBas Co., Ltd. | 728 Thousand JPY | -1627647.253% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -13386.906% |
| RaQualia Pharma Inc. | 147.93 Million JPY | -7910.058% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -18384.721% |
| Kidswell Bio Corporation | 875.65 Million JPY | -1253.274% |
| PeptiDream Inc. | 2.4 Billion JPY | -392.896% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -221727.031% |
| Ribomic Inc. | 2.27 Million JPY | -521008.179% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -1184999999900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -32816.667% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -40762.069% |
| CellSource Co., Ltd. | 305.92 Million JPY | -3773.498% |
| FunPep Company Limited | 25.54 Million JPY | -46295.991% |
| Kringle Pharma, Inc. | 364.05 Million JPY | -3154.994% |
| Stella Pharma Corporation | 1.11 Billion JPY | -961.584% |
| TMS Co., Ltd. | 50.02 Million JPY | -23588.156% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -56595.852% |
| Cuorips Inc. | 1.04 Million JPY | -1136045.733% |
| K Pharma,Inc. | 10.79 Million JPY | -109683.213% |
| ReproCELL Incorporated | 248.14 Million JPY | -4675.53% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | -2529.903% |
| StemCell Institute Inc. | 42.26 Million JPY | -27939.373% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | -5084.521% |
| CellSeed Inc. | 46.19 Million JPY | -25554.348% |